Nuvation Bio Announces up to $250 Million Nondilutive Financings From Sagard Healthcare Partners

San Francisco – March 3, 2025 – Cooley advised Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, on its nondilutive financings of up to $250 million with Sagard Healthcare Partners. The transaction comprises a royalty interest financing of $150 million and a senior term loan of up to $100 million. These financings strengthen Nuvation Bio’s balance sheet to fully fund commercialization of taletrectinib in the US, if approved, and development of its current clinical-stage pipeline. The transaction also provides Nuvation Bio with a path to potential profitability without the need to raise additional capital.

Lawyers Mischi a Marca, Addison Pierce, Shimeng Cheng, Rodrigo Huerta, Charles A. Watkins II and Kenneth Guernsey led the Cooley team advising Nuvation Bio, with support from patent counseling and prosecution partner Jonathan Cousin, life sciences partner Christophe Beauduin, life sciences and healthcare regulatory partner Sonia Nath, tax partners Aaron Pomeroy and Eileen Marshall, business restructuring partner Michael Neumeister and life sciences partner Yiming Liu.

Cooley previously advised Nuvation Bio on its acquisition of AnHeart Therapeutics in March 2024 and its merger with Panacea in October 2020.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.